Steven Shoelson, MD, Endocrinology, Boston, MA

StevenEShoelsonMD

Endocrinology Boston, MA

Professor of Medicine, Joslin Diabetes Center

Dr. Shoelson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shoelson's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes and Metabolism, 1988 - 1989
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1985 - 1988
  • University of Chicago Pritzker School of Medicine
    University of Chicago Pritzker School of MedicineClass of 1985

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1989 - 2021
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Natural Killer Cells Help to Drive Inflammation, Insulin Resistance
    Natural Killer Cells Help to Drive Inflammation, Insulin ResistanceApril 02, 2016 03:49
  • Health News - Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 Diabetes
    Health News - Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 DiabetesFebruary 10, 2016 16:15
  • Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 Diabetes
    Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 DiabetesFebruary 10, 2016 16:15

Grant Support

  • Nf-Kb, Inflammation And Vascular RemodelingNational Heart, Lung, And Blood Institute2006–2011
  • Mechanism-Based Biomarkers For Glucose-Lowering In Tinsal-T2dNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Mediators And Modifiers Of Nf-Kappab In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
  • Toll Receptor Activation Of Nf-Kb In Insulin Resistance And T2dmNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
  • Targeting Inflammation In Type 2 Diabetes: Clinical Trial Using SalsalateNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
  • Effects Of Ikkb And NFKB In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Ser/Thr Phosphorylation In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
  • Mediators And Modifiers Of Nf-Kb In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Effect Of Salicylate On Glucose Metabolism In Insulin Resistance StatesNational Center For Research Resources2004–2006
  • Effect Of Salicylate On Glucose Metabolism In Insulin Resistant StatesNational Center For Research Resources2005
  • Salicylate On Glucose Metabolism In Insulin Resistant STNational Center For Research Resources2004
  • Potential Cause &Molecular Target Of Insulin ResistancNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
  • IKK Mediated Insulin Resistance And In Vivo ReversalNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Structure Of IRS Proteins In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
  • Core--Peptide Biochemistry FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
  • Receptor/Substrate Complexes In Transmembrane SignalingNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • New SH2 Proteins In Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
  • Mapping The Insulin-Receptor InterfaceNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996